000 03089nam a22003737a 4500
001 D0001C000172
003 DOH
005 20210408141413.0
008 210408b ||||| |||| 00| 0 eng d
245 0 0 _aSerology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia /
_cYuan Liang Woon [and sixteen others]
520 3 _aBackground: Asymptomatic severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections are well documented. Healthcare workers (HCW) are at increased risk of infection due to occupational exposure to infected patients. We aim to determine the prevalence of SARS-CoV-2 antibodies among HCW who did not come to medical attention. Methods: We prospectively recruited 400 HCW from the National Public Health Laboratory and two COVID-19 designated public hospitals in Klang Valley, Malaysia between 13/4/2020 and 12/5/2020. Quota sampling was used to ensure representativeness of HCW involved in direct and indirect patient care. All participants answered a self-administered questionnaire and blood samples were taken to test for SARS-CoV-2 antibodies by surrogate virus neutralization test. Findings: The study population comprised 154 (38.5%) nurses, 103 (25.8%) medical doctors, 47 (11.8%) laboratory technologists and others (23.9%). A majority (68.9%) reported exposure to SARS-CoV-2 in the past month within their respective workplaces. Adherence to personal protection equipment (PPE) guidelines and hand hygiene were good, ranging from 91-100% compliance. None (95% CI: 0, 0.0095) of the participants had SARS-CoV-2 antibodies detected, despite 182 (45.5%) reporting some symptoms one month prior to study recruitment. One hundred and fifteen (29%) of participants claimed to have had contact with known COVID-19 persons outside of their workplace. Interpretation: Zero seroprevalence among HCW suggests a low incidence of undiagnosed COVID-19 infection in our healthcare setting during the first local wave of SARS-CoV-2 infection. The occupational risk of SARS-CoV-2 transmission within healthcare facilities can be prevented by adherence to infection control measures and appropriate use of PPE. © 2021 The Author(s).
580 _aLancet Reg Health West Pac. 2021 Apr 9: 100123 doi: 10.1016/j.lanwpc.2021.100123
650 2 _aCOVID-19 Serological Testing
650 2 _aHealth Personnel
700 1 _aWoon, Yuan Liang
700 1 _a Lee, Yee Leng
700 1 _aChong, Yoong Min
700 1 _aAyub, Nor Aliya
700 1 _aKrishnabahawan, Swarna Lata
700 1 _aLau, June Fei Wen
700 1 _aSubramaniam-Kalianan, Ramani
700 1 _aSam, I-Ching
700 1 _aChan, Yoke Fun
700 1 _aSevalingam, Raj Kumar
700 1 _aRamli, Azura
700 1 _aChuah, Chuan Huan
700 1 _aMat-Hussin, Hani
700 1 _aLeong, Chee Loon
700 1 _aChidambaram, Suresh Kumar
700 1 _aPeariasamy, Kalaiarasu M.
700 1 _aGoh, Pik Pin
856 _uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982055/
942 _cCV
999 _c3959
_d3959